Vespula pensylvanica isolate Volc-1 chromosome 7, ASM1446617v1, whole genome shotgun sequence.
Vespula pensylvanica (western yellowjacket)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Vespoidea; Vespidae; Vespinae; Vespula.
High-Quality Assemblies for Three Invasive Social Wasps from the Vespula Genus
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM025342.1.\nAssembly name: ASM1446617v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the University of Otago on\n2020/09/09. The original whole-genome shotgun project has the\naccession JACSDY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: University of Otago\nAssembly Date :: 03-JUL-2020\nAssembly Method :: meraculous v. 2.2.6\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 644x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Vespula pensylvanica Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X4
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X3
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X5
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X6
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X1
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X2
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X8
probable multidrug resistance-associated protein lethal(2)03659 isoform X3
probable multidrug resistance-associated protein lethal(2)03659 isoform X2
probable multidrug resistance-associated protein lethal(2)03659 isoform X1
probable multidrug resistance-associated protein lethal(2)03659 isoform X5
probable multidrug resistance-associated protein lethal(2)03659, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable multidrug resistance-associated protein lethal(2)03659 isoform X4
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X3
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X2
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X4
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X1
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X6
5-methylcytosine rRNA methyltransferase NSUN4, transcript variant X5
5-methylcytosine rRNA methyltransferase NSUN4
uncharacterized LOC122630554, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122630554, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tramtrack, beta isoform, transcript variant X7
protein tramtrack, beta isoform, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
protein tramtrack, beta isoform, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
protein tramtrack, beta isoform, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
protein tramtrack, beta isoform, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
protein tramtrack, beta isoform, transcript variant X2
protein tramtrack, beta isoform, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
protein tramtrack, beta isoform, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
protein tramtrack, alpha isoform isoform X1
protein tramtrack, beta isoform isoform X3
uncharacterized LOC122630552, transcript variant X8
uncharacterized LOC122630552, transcript variant X6
uncharacterized LOC122630552, transcript variant X1
uncharacterized LOC122630552, transcript variant X3
uncharacterized LOC122630552, transcript variant X2
uncharacterized LOC122630552, transcript variant X4
uncharacterized LOC122630552, transcript variant X7
uncharacterized LOC122630552, transcript variant X5
aspartate aminotransferase, mitochondrial, transcript variant X2
aspartate aminotransferase, mitochondrial, transcript variant X1
aspartate aminotransferase, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 76% coverage of the annotated genomic feature by RNAseq alignments
probable sodium/potassium/calcium exchanger CG1090
UDP-glucosyltransferase 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 137 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 126 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 137 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 138 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
UDP-glucosyltransferase 2-like isoform X1
UDP-glucosyltransferase 2-like isoform X3
UDP-glucosyltransferase 2-like isoform X2
UDP-glucosyltransferase 2-like isoform X4
uncharacterized LOC122630431, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122630431, transcript variant X1
uncharacterized protein LOC122630431 isoform X2
uncharacterized protein LOC122630431 isoform X1
COMM domain-containing protein 4, transcript variant X1
uncharacterized LOC122630435, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC122630435, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC122630435 isoform X2
uncharacterized protein LOC122630435 isoform X1
COMM domain-containing protein 4, transcript variant X2
uncharacterized LOC122630432, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122630432, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nuclear envelope integral membrane protein 1, transcript variant X1
nuclear envelope integral membrane protein 1 isoform X1
nuclear envelope integral membrane protein 1, transcript variant X2
nuclear envelope integral membrane protein 1 isoform X2
tubulin epsilon chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tubulin epsilon chain-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
tubulin epsilon chain-like, transcript variant X3
cytoplasmic polyadenylation element-binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
cytoplasmic polyadenylation element-binding protein 2 isoform X1
cytoplasmic polyadenylation element-binding protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
LIM domain-binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LIM domain-binding protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
proline-rich protein 2-like, transcript variant X4
proline-rich protein 2-like, transcript variant X7
proline-rich protein 2-like, transcript variant X6
proline-rich protein 2-like, transcript variant X2
proline-rich protein 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
proline-rich protein 2-like, transcript variant X8
proline-rich protein 2-like, transcript variant X1
proline-rich protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC122630604, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122630604, transcript variant X1
uncharacterized LOC122630604, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized protein LOC122630604 isoform X2
uncharacterized protein LOC122630604 isoform X1
uncharacterized protein LOC122630604 isoform X3
uncharacterized LOC122630606, transcript variant X1
uncharacterized LOC122630606, transcript variant X3
uncharacterized LOC122630606, transcript variant X2
uncharacterized protein LOC122630606 isoform X1
uncharacterized protein LOC122630606 isoform X2
transmembrane protein 230, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
transmembrane protein 230, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
MATH and LRR domain-containing protein PFE0570w-like isoform X1
MATH and LRR domain-containing protein PFE0570w-like isoform X2
replication factor C subunit 5, transcript variant X4
replication factor C subunit 5, transcript variant X2
replication factor C subunit 5, transcript variant X3
replication factor C subunit 5, transcript variant X1
replication factor C subunit 5 isoform X4
replication factor C subunit 5 isoform X2
replication factor C subunit 5 isoform X3
replication factor C subunit 5 isoform X1
26S proteasome non-ATPase regulatory subunit 6-like
uncharacterized LOC122630455, transcript variant X5
uncharacterized LOC122630455, transcript variant X4
uncharacterized LOC122630455, transcript variant X2
uncharacterized LOC122630455, transcript variant X7
uncharacterized LOC122630455, transcript variant X6
uncharacterized LOC122630455, transcript variant X3
uncharacterized LOC122630455, transcript variant X1
uncharacterized LOC122630455, transcript variant X8
uncharacterized protein LOC122630455 isoform X4
uncharacterized protein LOC122630455 isoform X6
uncharacterized protein LOC122630455 isoform X5
uncharacterized protein LOC122630455 isoform X3
uncharacterized protein LOC122630455 isoform X2
uncharacterized protein LOC122630455 isoform X1
uncharacterized protein LOC122630455 isoform X7
uncharacterized LOC122630350, transcript variant X2
uncharacterized LOC122630350, transcript variant X3
uncharacterized LOC122630350, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM14, transcript variant X2
mitochondrial import inner membrane translocase subunit TIM14 isoform X2
mitochondrial import inner membrane translocase subunit TIM14, transcript variant X1
mitochondrial import inner membrane translocase subunit TIM14 isoform X1
growth hormone-regulated TBC protein 1-A, transcript variant X1
growth hormone-regulated TBC protein 1-A, transcript variant X2
growth hormone-regulated TBC protein 1-A isoform X2
growth hormone-regulated TBC protein 1-A isoform X1
eukaryotic translation initiation factor 2A
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X5
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X6
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X2
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X4
probable ubiquitin carboxyl-terminal hydrolase FAF-X, transcript variant X3
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X1
probable ubiquitin carboxyl-terminal hydrolase FAF-X isoform X2
peroxisomal (S)-2-hydroxy-acid oxidase GLO5, transcript variant X2
peroxisomal (S)-2-hydroxy-acid oxidase GLO5, transcript variant X1
peroxisomal (S)-2-hydroxy-acid oxidase GLO5, transcript variant X3
peroxisomal (S)-2-hydroxy-acid oxidase GLO5, transcript variant X4
peroxisomal (S)-2-hydroxy-acid oxidase GLO5
N-acetylgalactosaminyltransferase 6-like
TLD domain-containing protein 2, transcript variant X14
TLD domain-containing protein 2, transcript variant X12
TLD domain-containing protein 2, transcript variant X11
TLD domain-containing protein 2, transcript variant X10
TLD domain-containing protein 2, transcript variant X4
TLD domain-containing protein 2, transcript variant X2
TLD domain-containing protein 2, transcript variant X1
TLD domain-containing protein 2, transcript variant X3
TLD domain-containing protein 2, transcript variant X5
TLD domain-containing protein 2, transcript variant X7
TLD domain-containing protein 2, transcript variant X6
TLD domain-containing protein 2, transcript variant X8
TLD domain-containing protein 2, transcript variant X9
TLD domain-containing protein 2, transcript variant X13
TLD domain-containing protein 2, transcript variant X15
TLD domain-containing protein 2, transcript variant X16
oxidation resistance protein 1 isoform X14
oxidation resistance protein 1 isoform X12
oxidation resistance protein 1 isoform X11
oxidation resistance protein 1 isoform X10
uncharacterized protein LOC122630527 isoform X4
uncharacterized protein LOC122630527 isoform X2
nuclear receptor coactivator 7 isoform X9
nuclear receptor coactivator 7 isoform X8
nuclear receptor coactivator 7 isoform X7
nuclear receptor coactivator 7 isoform X6
nuclear receptor coactivator 7 isoform X3
uncharacterized protein LOC122630527 isoform X5
uncharacterized protein LOC122630527 isoform X1
oxidation resistance protein 1 isoform X13
TLD domain-containing protein 2 isoform X15
TLD domain-containing protein 2 isoform X16
39S ribosomal protein L11, mitochondrial
cilia- and flagella-associated protein 36
serine/threonine-protein phosphatase 4 regulatory subunit 3, transcript variant X1
serine/threonine-protein phosphatase 4 regulatory subunit 3, transcript variant X2
serine/threonine-protein phosphatase 4 regulatory subunit 3 isoform X2
serine/threonine-protein phosphatase 4 regulatory subunit 3 isoform X1
E3 ubiquitin-protein ligase synoviolin A, transcript variant X3
E3 ubiquitin-protein ligase synoviolin A, transcript variant X2
E3 ubiquitin-protein ligase synoviolin A, transcript variant X1
E3 ubiquitin-protein ligase synoviolin A isoform X2
E3 ubiquitin-protein ligase synoviolin A isoform X1
rho GTPase-activating protein 24-like, transcript variant X3
rho GTPase-activating protein 24-like, transcript variant X2
rho GTPase-activating protein 24-like, transcript variant X1
rho GTPase-activating protein 24-like isoform X2
rho GTPase-activating protein 24-like isoform X1
aldo-keto reductase family 1 member A1-like, transcript variant X2
aldo-keto reductase family 1 member A1-like isoform X2
aldo-keto reductase family 1 member A1-like, transcript variant X1
aldo-keto reductase family 1 member A1-like isoform X1
aldo-keto reductase family 1 member A1-like, transcript variant X3
aldo-keto reductase family 1 member A1-like, transcript variant X4
aldo-keto reductase family 1 member A1-like isoform X3
replication stress response regulator SDE2
CLIP domain-containing serine protease B9-like
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: CLIP domain-containing serine protease B9-like
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial isoform X1
ubiquinone biosynthesis monooxygenase COQ6, mitochondrial isoform X2
transient receptor potential channel pyrexia-like, transcript variant X2
transient receptor potential channel pyrexia-like, transcript variant X1
transient receptor potential channel pyrexia-like
uncharacterized LOC122630600, transcript variant X2
uncharacterized LOC122630600, transcript variant X1
uncharacterized LOC122630600, transcript variant X3
RNA-binding protein Nova-1, transcript variant X5
RNA-binding protein Nova-1, transcript variant X1
RNA-binding protein Nova-1, transcript variant X2
RNA-binding protein Nova-1, transcript variant X3
RNA-binding protein Nova-1, transcript variant X4
molybdopterin synthase catalytic subunit, transcript variant X3
molybdopterin synthase catalytic subunit, transcript variant X4
molybdopterin synthase catalytic subunit, transcript variant X2
molybdopterin synthase catalytic subunit, transcript variant X1
molybdopterin synthase catalytic subunit
tubulin polyglutamylase TTLL5, transcript variant X1
tubulin polyglutamylase TTLL5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122630583, transcript variant X5
uncharacterized protein LOC122630583 isoform X3
tubulin polyglutamylase TTLL5 isoform X1
tubulin polyglutamylase TTLL5 isoform X2
uncharacterized LOC122630583, transcript variant X2
uncharacterized LOC122630583, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC122630583, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC122630583, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC122630583 isoform X1
uncharacterized protein LOC122630583 isoform X2
tubulin polyglutamylase TTLL5, transcript variant X3
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
tubulin polyglutamylase TTLL5 isoform X3
RNA 3'-terminal phosphate cyclase, transcript variant X2
RNA 3'-terminal phosphate cyclase, transcript variant X1
RNA 3'-terminal phosphate cyclase isoform X1
RNA 3'-terminal phosphate cyclase isoform X2
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X3
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X5
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X2
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X4
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase, transcript variant X1
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase isoform X2
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase isoform X1
GDP-Man:Man(3)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase isoform X3
copper-transporting ATPase 1, transcript variant X1
copper-transporting ATPase 1, transcript variant X2
copper-transporting ATPase 1, transcript variant X5
copper-transporting ATPase 1, transcript variant X4
copper-transporting ATPase 1, transcript variant X3
serine/threonine-protein kinase BRSK2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2 isoform X8
serine/threonine-protein kinase BRSK2 isoform X6
serine/threonine-protein kinase BRSK2 isoform X2
serine/threonine-protein kinase BRSK2 isoform X3
serine/threonine-protein kinase BRSK2 isoform X1
serine/threonine-protein kinase BRSK2 isoform X7
serine/threonine-protein kinase BRSK2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
serine/threonine-protein kinase BRSK2 isoform X4
serine/threonine-protein kinase BRSK2, transcript variant X5
serine/threonine-protein kinase BRSK2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
mitogen-activated protein kinase-binding protein 1, transcript variant X1
mitogen-activated protein kinase-binding protein 1, transcript variant X2
mitogen-activated protein kinase-binding protein 1, transcript variant X3
mitogen-activated protein kinase-binding protein 1, transcript variant X7
mitogen-activated protein kinase-binding protein 1, transcript variant X6
mitogen-activated protein kinase-binding protein 1, transcript variant X5
mitogen-activated protein kinase-binding protein 1, transcript variant X9
mitogen-activated protein kinase-binding protein 1, transcript variant X4
uncharacterized protein LOC122630575 isoform X4
mitogen-activated protein kinase-binding protein 1 isoform X7
uncharacterized protein LOC122630575 isoform X5
uncharacterized protein LOC122630575 isoform X3
uncharacterized protein LOC122630575 isoform X1
uncharacterized protein LOC122630575 isoform X2
mitogen-activated protein kinase-binding protein 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC122630575 isoform X6
synaptotagmin-1-like, transcript variant X3
synaptotagmin-1-like, transcript variant X1
synaptotagmin-1-like, transcript variant X2
uncharacterized LOC122630596, transcript variant X1
uncharacterized LOC122630596, transcript variant X4
uncharacterized LOC122630596, transcript variant X3
uncharacterized LOC122630596, transcript variant X2
uncharacterized LOC122630593, transcript variant X6
uncharacterized LOC122630593, transcript variant X5
uncharacterized LOC122630593, transcript variant X3
uncharacterized LOC122630593, transcript variant X4
uncharacterized LOC122630593, transcript variant X2
uncharacterized LOC122630593, transcript variant X1
uncharacterized LOC122630558, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122630558, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized protein LOC122630558 isoform X2
uncharacterized protein LOC122630558 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
ribosome biogenesis protein BRX1 homolog
probable rRNA-processing protein EBP2 homolog
uncharacterized LOC122630746, transcript variant X2
uncharacterized LOC122630746, transcript variant X1
uncharacterized LOC122630746, transcript variant X3
uncharacterized protein LOC122630746 isoform X1
uncharacterized LOC122630746, transcript variant X4
uncharacterized protein LOC122630746 isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X6
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X7
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X13
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X11
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X10
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X12
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X18
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X14
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X2
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X1
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X4
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X5
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X3
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X15
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X8
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X9
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X16
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G, transcript variant X17
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X6
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X11
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X10
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X12
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X4
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X1
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X13
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X8
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X9
cAMP-specific 3',5'-cyclic phosphodiesterase, isoforms N/G isoform X5
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X3
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X7
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X14
cAMP-specific 3',5'-cyclic phosphodiesterase isoform X15
cyclin-dependent kinase inhibitor 1C-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
probable serine/threonine-protein kinase kinX
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 56% coverage of the annotated genomic feature by RNAseq alignments
proteasome adapter and scaffold protein ECM29
uncharacterized LOC122630786, transcript variant X2
uncharacterized LOC122630786, transcript variant X1
uncharacterized protein LOC122630786 isoform X2
uncharacterized protein LOC122630786 isoform X1
LMBR1 domain-containing protein 2 homolog
protein aurora borealis, transcript variant X1
protein aurora borealis, transcript variant X2
dnaJ homolog dnj-5, transcript variant X4
dnaJ homolog dnj-5, transcript variant X1
dnaJ homolog dnj-5, transcript variant X2
dnaJ homolog dnj-5, transcript variant X3
uncharacterized LOC122630683, transcript variant X1
uncharacterized LOC122630683, transcript variant X2
uncharacterized protein LOC122630683 isoform X1
uncharacterized protein LOC122630683 isoform X2
death-associated protein kinase 1-like, transcript variant X1
death-associated protein kinase 1-like, transcript variant X4
death-associated protein kinase 1-like, transcript variant X3
death-associated protein kinase 1-like, transcript variant X2
death-associated protein kinase 1-like isoform X1
death-associated protein kinase 1-like isoform X3
death-associated protein kinase 1-like isoform X2
tropomyosin-2-like, transcript variant X2
tropomyosin-2-like, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X5
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X3
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X4
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X1
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X6
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X15
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X2
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X14
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X9
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X5
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X3
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X4
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X1
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X6
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X12
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X2
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X11
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X7
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X8
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X11
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X9
Down syndrome cell adhesion molecule-like protein Dscam2 isoform X10
Down syndrome cell adhesion molecule-like protein Dscam2, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
endoplasmic reticulum resident protein 44, transcript variant X1
endoplasmic reticulum resident protein 44, transcript variant X2
endoplasmic reticulum resident protein 44 isoform X1
endoplasmic reticulum resident protein 44 isoform X2
neo-calmodulin-like, transcript variant X3
neo-calmodulin-like, transcript variant X4
neo-calmodulin-like, transcript variant X5
neo-calmodulin-like, transcript variant X1
neo-calmodulin-like, transcript variant X2
neo-calmodulin-like, transcript variant X6
broad-complex core protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
broad-complex core protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
broad-complex core protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
broad-complex core protein, transcript variant X3
broad-complex core protein, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5 isoform X2
broad-complex core protein isoforms 1/2/3/4/5 isoform X1
broad-complex core protein, transcript variant X9
broad-complex core protein, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5 isoform X6
broad-complex core protein isoforms 1/2/3/4/5 isoform X5
broad-complex core protein, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5 isoform X10
broad-complex core protein, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
broad-complex core protein, transcript variant X12
broad-complex core protein isoforms 1/2/3/4/5 isoform X11
broad-complex core protein isoforms 1/2/3/4/5 isoform X9
broad-complex core protein, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
broad-complex core protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
broad-complex core protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
broad-complex core protein, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
broad-complex core protein isoforms 1/2/3/4/5 isoform X4
broad-complex core protein isoforms 1/2/3/4/5 isoform X3
uncharacterized LOC122630343, transcript variant X1
uncharacterized LOC122630343, transcript variant X2
UPF0764 protein C16orf89, transcript variant X1
UPF0764 protein C16orf89, transcript variant X3
UPF0764 protein C16orf89, transcript variant X2
uncharacterized protein LOC122630315 isoform X1
uncharacterized protein LOC122630315 isoform X2
uncharacterized LOC122630314, transcript variant X2
uncharacterized LOC122630314, transcript variant X3
uncharacterized LOC122630314, transcript variant X5
uncharacterized LOC122630314, transcript variant X4
uncharacterized LOC122630314, transcript variant X1
uncharacterized protein LOC122630314 isoform X2
uncharacterized protein LOC122630314 isoform X1
uncharacterized protein LOC122630314 isoform X3
uncharacterized LOC122630314, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122630314, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X2
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X1
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X2
CCA tRNA nucleotidyltransferase 1, mitochondrial, transcript variant X3
CCA tRNA nucleotidyltransferase 1, mitochondrial isoform X3
vacuolar protein sorting-associated protein 37A
procollagen-lysine,2-oxoglutarate 5-dioxygenase
immunoglobulin domain-containing protein oig-4-like, transcript variant X3
immunoglobulin domain-containing protein oig-4-like, transcript variant X1
immunoglobulin domain-containing protein oig-4-like isoform X1
immunoglobulin domain-containing protein oig-4-like, transcript variant X2
immunoglobulin domain-containing protein oig-4-like isoform X2
transcription initiation factor IIA subunit 1, transcript variant X1
transcription initiation factor IIA subunit 1, transcript variant X2
transcription initiation factor IIA subunit 1, transcript variant X3
transcription initiation factor IIA subunit 1, transcript variant X4
transcription initiation factor IIA subunit 1 isoform X3
transcription initiation factor IIA subunit 1 isoform X1
transcription initiation factor IIA subunit 1 isoform X2
scavenger receptor class B member 1, transcript variant X2
scavenger receptor class B member 1, transcript variant X3
scavenger receptor class B member 1, transcript variant X1
scavenger receptor class B member 1, transcript variant X4
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 9-like, transcript variant X3
A disintegrin and metalloproteinase with thrombospondin motifs 9-like
uncharacterized LOC122630826, transcript variant X1
uncharacterized LOC122630826, transcript variant X2
uncharacterized protein LOC122630826 isoform X2
uncharacterized protein LOC122630826 isoform X1
peptidyl-prolyl cis-trans isomerase-like
guanine nucleotide-binding protein subunit beta-2
JNK-interacting protein 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
JNK-interacting protein 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
JNK-interacting protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
JNK-interacting protein 3, transcript variant X3
JNK-interacting protein 3, transcript variant X2
JNK-interacting protein 3, transcript variant X1
JNK-interacting protein 3, transcript variant X4
transcription factor Sp9-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcription factor Sp9-like, transcript variant X5
transcription factor Sp9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcription factor Sp9-like isoform X1
transcription factor Sp9-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
transcription factor Sp9-like isoform X2
transcription factor Sp9-like, transcript variant X6
transcription factor Sp9-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
transcription factor Sp9-like isoform X3
transcription factor Sp9-like isoform X4
obg-like ATPase 1, transcript variant X1
obg-like ATPase 1, transcript variant X2
uncharacterized LOC122630645, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122630645, transcript variant X4
uncharacterized LOC122630645, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC122630645, transcript variant X1
uncharacterized protein LOC122630645 isoform X3
uncharacterized protein LOC122630645 isoform X2
uncharacterized protein LOC122630645 isoform X4
uncharacterized protein LOC122630645 isoform X1
SPARC-related modular calcium-binding protein 2, transcript variant X1
SPARC-related modular calcium-binding protein 2, transcript variant X6
SPARC-related modular calcium-binding protein 2, transcript variant X7
SPARC-related modular calcium-binding protein 2, transcript variant X5
SPARC-related modular calcium-binding protein 2 isoform X1
SPARC-related modular calcium-binding protein 2 isoform X3
SPARC-related modular calcium-binding protein 2 isoform X4
SPARC-related modular calcium-binding protein 2, transcript variant X3
SPARC-related modular calcium-binding protein 2, transcript variant X4
SPARC-related modular calcium-binding protein 2, transcript variant X2
SPARC-related modular calcium-binding protein 2 isoform X2
cyclin-dependent kinase 9, transcript variant X2
cyclin-dependent kinase 9, transcript variant X1
deoxynucleoside kinase, transcript variant X1
deoxynucleoside kinase, transcript variant X2
protein immune deficiency, transcript variant X1
protein immune deficiency, transcript variant X2
protein C1orf43 homolog, transcript variant X1
protein C1orf43 homolog, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5
uncharacterized LOC122630653, transcript variant X3
uncharacterized LOC122630653, transcript variant X1
uncharacterized LOC122630653, transcript variant X4
uncharacterized LOC122630653, transcript variant X2
uncharacterized protein LOC122630653 isoform X1
uncharacterized protein LOC122630653 isoform X2
uncharacterized protein LOC122630653 isoform X3
kinesin-like protein KIF2A, transcript variant X7
kinesin-like protein KIF2A, transcript variant X9
kinesin-like protein KIF2A, transcript variant X8
kinesin-like protein KIF2A, transcript variant X4
kinesin-like protein KIF2A, transcript variant X5
kinesin-like protein KIF2A, transcript variant X6
kinesin-like protein KIF2A, transcript variant X1
kinesin-like protein KIF2A, transcript variant X2
kinesin-like protein KIF2A, transcript variant X3
uncharacterized protein LOC122630652 isoform X1
uncharacterized protein LOC122630652 isoform X3
protein adenylyltransferase Fic, transcript variant X2
protein adenylyltransferase Fic, transcript variant X1
protein adenylyltransferase Fic isoform X2
protein adenylyltransferase Fic isoform X1
ADP-ribosylation factor-like protein 16, transcript variant X3
ADP-ribosylation factor-like protein 16, transcript variant X2
ADP-ribosylation factor-like protein 16, transcript variant X1
ADP-ribosylation factor-like protein 16 isoform X3
ADP-ribosylation factor-like protein 16 isoform X2
ADP-ribosylation factor-like protein 16 isoform X1
MATH and LRR domain-containing protein PFE0570w-like, transcript variant X3
MATH and LRR domain-containing protein PFE0570w-like isoform X3
E3 ubiquitin ligase Rnf157, transcript variant X1
E3 ubiquitin ligase Rnf157, transcript variant X2
mediator of RNA polymerase II transcription subunit 9
GTP-binding protein 1, transcript variant X2
GTP-binding protein 1, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X1
probable cytosolic Fe-S cluster assembly factor AGAP009023, transcript variant X2
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X1
probable cytosolic Fe-S cluster assembly factor AGAP009023 isoform X2
regulator of microtubule dynamics protein 1-like, transcript variant X3
regulator of microtubule dynamics protein 1-like, transcript variant X2
regulator of microtubule dynamics protein 1-like, transcript variant X1
regulator of microtubule dynamics protein 1-like isoform X1
regulator of microtubule dynamics protein 1-like isoform X2
lysocardiolipin acyltransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lysocardiolipin acyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
lysocardiolipin acyltransferase 1-like, transcript variant X2
lysocardiolipin acyltransferase 1-like isoform X2
lysocardiolipin acyltransferase 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
coiled-coil domain-containing protein 134-like
NADH-cytochrome b5 reductase-like, transcript variant X1
NADH-cytochrome b5 reductase-like, transcript variant X2
NADH-cytochrome b5 reductase-like, transcript variant X3
NADH-cytochrome b5 reductase-like isoform X1
NADH-cytochrome b5 reductase-like isoform X2
NADH-cytochrome b5 reductase-like isoform X3
glucose-6-phosphate exchanger SLC37A2, transcript variant X1
glucose-6-phosphate exchanger SLC37A2, transcript variant X2
glucose-6-phosphate exchanger SLC37A2 isoform X1
glucose-6-phosphate exchanger SLC37A2 isoform X2
glucose-6-phosphate exchanger SLC37A2, transcript variant X3
glucose-6-phosphate exchanger SLC37A2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
uncharacterized LOC122630325, transcript variant X2
uncharacterized LOC122630325, transcript variant X1
uncharacterized LOC122630325, transcript variant X3
uncharacterized protein LOC122630325 isoform X2
uncharacterized protein LOC122630325 isoform X1
uncharacterized LOC122630397, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122630397, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
alpha-tocopherol transfer protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
alpha-tocopherol transfer protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 31, transcript variant X1
mediator of RNA polymerase II transcription subunit 31, transcript variant X2
solute carrier family 22 member 8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
mediator of RNA polymerase II transcription subunit 31
solute carrier family 22 member 8-like, transcript variant X2
solute carrier family 22 member 8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 22 member 8-like isoform X2
solute carrier family 22 member 8-like isoform X1
uncharacterized LOC122630397, transcript variant X1
uncharacterized LOC122630397, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
structure-specific endonuclease subunit slx1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
structure-specific endonuclease subunit slx1, transcript variant X2
structure-specific endonuclease subunit slx1 isoform X1
structure-specific endonuclease subunit slx1 isoform X2
fructose-bisphosphate aldolase, transcript variant X1
fructose-bisphosphate aldolase, transcript variant X3
fructose-bisphosphate aldolase, transcript variant X2
fructose-bisphosphate aldolase isoform X2
fructose-bisphosphate aldolase isoform X1
fructose-bisphosphate aldolase 5, cytosolic-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
ADP-ribosylation factor-like protein 6-interacting protein 4, transcript variant X2
ADP-ribosylation factor-like protein 6-interacting protein 4, transcript variant X1
ADP-ribosylation factor-like protein 6-interacting protein 4
probable citrate synthase, mitochondrial, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
probable citrate synthase, mitochondrial, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
probable citrate synthase, mitochondrial, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
RING finger and transmembrane domain-containing protein 2-like isoform X3
RING finger and transmembrane domain-containing protein 2-like isoform X4
probable citrate synthase, mitochondrial, transcript variant X2
probable citrate synthase, mitochondrial, transcript variant X1
probable citrate synthase, mitochondrial isoform X2
probable citrate synthase, mitochondrial isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone], transcript variant X2
glucose dehydrogenase [FAD, quinone], transcript variant X1
glucose dehydrogenase [FAD, quinone] isoform X1
glucose dehydrogenase [FAD, quinone] isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
leucine-rich repeat-containing protein 47-like
uncharacterized LOC122630372, transcript variant X4
uncharacterized protein LOC122630372 isoform X3
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
uncharacterized LOC122630372, transcript variant X1
uncharacterized LOC122630372, transcript variant X3
uncharacterized LOC122630372, transcript variant X5
uncharacterized LOC122630372, transcript variant X2
uncharacterized protein LOC122630372 isoform X1
uncharacterized protein LOC122630372 isoform X2
uncharacterized protein LOC122630372 isoform X4
metabotropic glutamate receptor-like protein R, transcript variant X1
metabotropic glutamate receptor-like protein R, transcript variant X3
metabotropic glutamate receptor-like protein R, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
probable serine/threonine-protein kinase DDB_G0282963 isoform X1
metabotropic glutamate receptor-like protein R isoform X2
ran GTPase-activating protein 1, transcript variant X2
ran GTPase-activating protein 1, transcript variant X1
ran GTPase-activating protein 1, transcript variant X3
bromodomain-containing protein DDB_G0280777-like, transcript variant X2
bromodomain-containing protein DDB_G0280777-like, transcript variant X1
bromodomain-containing protein DDB_G0280777-like, transcript variant X3
bromodomain-containing protein DDB_G0280777-like isoform X2
bromodomain-containing protein DDB_G0280777-like isoform X1
bromodomain-containing protein DDB_G0280777-like isoform X3
methionine-R-sulfoxide reductase B1, transcript variant X3
methionine-R-sulfoxide reductase B1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
methionine-R-sulfoxide reductase B1, transcript variant X4
methionine-R-sulfoxide reductase B1, transcript variant X1
methionine-R-sulfoxide reductase B1, transcript variant X2
methionine-R-sulfoxide reductase B1 isoform X1
methionine-R-sulfoxide reductase B1 isoform X2
methionine-R-sulfoxide reductase B1 isoform X3
methionine-R-sulfoxide reductase B1 isoform X5
methionine-R-sulfoxide reductase B1 isoform X4
serine/threonine-protein kinase Pak, transcript variant X7
serine/threonine-protein kinase Pak, transcript variant X6
serine/threonine-protein kinase Pak, transcript variant X4
serine/threonine-protein kinase Pak, transcript variant X5
serine/threonine-protein kinase Pak, transcript variant X2
serine/threonine-protein kinase Pak, transcript variant X1
serine/threonine-protein kinase Pak, transcript variant X3
serine/threonine-protein kinase Pak isoform X3
serine/threonine-protein kinase Pak isoform X7
serine/threonine-protein kinase Pak isoform X6
serine/threonine-protein kinase Pak isoform X5
serine/threonine-protein kinase Pak isoform X4
serine/threonine-protein kinase Pak isoform X2
serine/threonine-protein kinase Pak isoform X1
beta carbonic anhydrase 1, transcript variant X1
beta carbonic anhydrase 1, transcript variant X3
beta carbonic anhydrase 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
beta carbonic anhydrase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
beta carbonic anhydrase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122630316, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
uncharacterized LOC122630316, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC122630316, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122630316, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
proline-, glutamic acid- and leucine-rich protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ATP-dependent RNA helicase DDX3X, transcript variant X1
ATP-dependent RNA helicase DDX3X, transcript variant X2
5'-nucleotidase domain-containing protein 3, transcript variant X1
5'-nucleotidase domain-containing protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
5'-nucleotidase domain-containing protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
5'-nucleotidase domain-containing protein 3 isoform X2
5'-nucleotidase domain-containing protein 3 isoform X1
uncharacterized LOC122630739, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122630739, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122630739, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122630739, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122630739, transcript variant X2
uncharacterized protein LOC122630739 isoform X1
uncharacterized LOC122630739, transcript variant X7
uncharacterized LOC122630739, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC122630739 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 68% coverage of the annotated genomic feature by RNAseq alignments
tyrosine-protein kinase Drl, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tyrosine-protein kinase Drl, transcript variant X2
transcription factor Ken, transcript variant X1
transcription factor Ken, transcript variant X2
apolipoprotein D-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
apolipoprotein D-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
apolipoprotein D-like, transcript variant X2
apolipoprotein D-like, transcript variant X3
apolipoprotein D-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB1-like, transcript variant X1
DNA-directed RNA polymerase II subunit RPB1-like, transcript variant X2
DNA-directed RNA polymerase II subunit RPB1-like
uncharacterized LOC122630351, transcript variant X2
uncharacterized LOC122630351, transcript variant X1
uncharacterized LOC122630351, transcript variant X3
gem-associated protein 7-like, transcript variant X1
gem-associated protein 7-like, transcript variant X2
mediator of RNA polymerase II transcription subunit 30, transcript variant X1
mediator of RNA polymerase II transcription subunit 30, transcript variant X2
mediator of RNA polymerase II transcription subunit 30 isoform X1
mediator of RNA polymerase II transcription subunit 30 isoform X2
RNA-binding protein 24-B-like, transcript variant X2
RNA-binding protein 24-B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
solute carrier organic anion transporter family member 74D, transcript variant X2
solute carrier organic anion transporter family member 74D, transcript variant X3
solute carrier organic anion transporter family member 74D, transcript variant X1
solute carrier organic anion transporter family member 74D isoform X1
solute carrier organic anion transporter family member 74D, transcript variant X4
solute carrier organic anion transporter family member 74D isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
solute carrier organic anion transporter family member 2A1-like
KAT8 regulatory NSL complex subunit 1, transcript variant X1
KAT8 regulatory NSL complex subunit 1 isoform X1
KAT8 regulatory NSL complex subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
KAT8 regulatory NSL complex subunit 1 isoform X2
excitatory amino acid transporter 1-like
single-stranded DNA-binding protein 3, transcript variant X6
single-stranded DNA-binding protein 3, transcript variant X3
single-stranded DNA-binding protein 3, transcript variant X2
single-stranded DNA-binding protein 3, transcript variant X1
single-stranded DNA-binding protein 3, transcript variant X5
single-stranded DNA-binding protein 3, transcript variant X4
single-stranded DNA-binding protein 3 isoform X1
single-stranded DNA-binding protein 3 isoform X6
single-stranded DNA-binding protein 3 isoform X2
single-stranded DNA-binding protein 3 isoform X4
single-stranded DNA-binding protein 3 isoform X5
single-stranded DNA-binding protein 3 isoform X3
glycine receptor subunit alpha-3, transcript variant X3
glycine receptor subunit alpha-3 isoform X3
glycine receptor subunit alpha-3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glycine receptor subunit alpha-3, transcript variant X1
glycine receptor subunit alpha-3, transcript variant X2
glycine receptor subunit alpha-3 isoform X1
glycine receptor subunit alpha-3 isoform X2
glycine receptor subunit alpha-3 isoform X4
laminin subunit beta-1, transcript variant X1
laminin subunit beta-1, transcript variant X2
protein trapped in endoderm-1, transcript variant X1
protein trapped in endoderm-1, transcript variant X2
protein trapped in endoderm-1, transcript variant X3
death-inducer obliterator 1, transcript variant X4
death-inducer obliterator 1, transcript variant X2
death-inducer obliterator 1, transcript variant X3
death-inducer obliterator 1, transcript variant X1
death-inducer obliterator 1, transcript variant X5
death-inducer obliterator 1, transcript variant X6
uncharacterized protein LOC122630707 isoform X2
uncharacterized protein LOC122630707 isoform X3
uncharacterized protein LOC122630707 isoform X1
uncharacterized protein LOC122630707 isoform X4
methionine--tRNA ligase, mitochondrial, transcript variant X2
methionine--tRNA ligase, mitochondrial isoform X2
methionine--tRNA ligase, mitochondrial, transcript variant X1
methionine--tRNA ligase, mitochondrial isoform X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X3
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X1
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X2
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X6
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X5
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like, transcript variant X4
galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase P-like
putative Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase
protein abrupt-like, transcript variant X4
protein abrupt-like, transcript variant X5
protein abrupt-like, transcript variant X1
protein abrupt-like, transcript variant X2
protein abrupt-like, transcript variant X3
actin-interacting protein 1, transcript variant X2
actin-interacting protein 1, transcript variant X1
uncharacterized PE-PGRS family protein PE_PGRS54-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X5
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X8
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X16
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X7
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X14
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X15
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X6
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X13
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X11
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X9
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X10
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X10
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X9
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X4
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X7
phosphatidylinositol-binding clathrin assembly protein LAP isoform X15
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X6
phosphatidylinositol-binding clathrin assembly protein LAP isoform X13
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X3
phosphatidylinositol-binding clathrin assembly protein LAP isoform X14
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X5
phosphatidylinositol-binding clathrin assembly protein LAP isoform X12
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X2
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X8
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X1
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
phosphatidylinositol-binding clathrin assembly protein unc-11 isoform X11
KICSTOR complex protein kaptin-like, transcript variant X2
KICSTOR complex protein kaptin-like, transcript variant X1
KICSTOR complex protein kaptin-like, transcript variant X3
KICSTOR complex protein kaptin-like, transcript variant X4
KICSTOR complex protein kaptin-like isoform X2
KICSTOR complex protein kaptin-like isoform X1
KICSTOR complex protein kaptin-like isoform X3
little elongation complex subunit 2-like, transcript variant X1
little elongation complex subunit 2-like, transcript variant X2
little elongation complex subunit 2-like isoform X1
little elongation complex subunit 2-like isoform X2
zinc finger protein 148-like, transcript variant X4
zinc finger protein 148-like, transcript variant X3
zinc finger protein 148-like, transcript variant X2
zinc finger protein 148-like, transcript variant X1
uncharacterized protein MAL13P1.304-like isoform X2
guanine nucleotide-binding protein subunit beta-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial
oligoribonuclease, mitochondrial, transcript variant X1
oligoribonuclease, mitochondrial, transcript variant X3
oligoribonuclease, mitochondrial isoform X3
oligoribonuclease, mitochondrial, transcript variant X2
oligoribonuclease, mitochondrial isoform X2
Kv channel-interacting protein 2-like, transcript variant X1
Kv channel-interacting protein 2-like, transcript variant X2
Kv channel-interacting protein 2-like, transcript variant X3
Kv channel-interacting protein 1-like isoform X1
Kv channel-interacting protein 2-like isoform X2
Kv channel-interacting protein 2-like isoform X3
probable 28S ribosomal protein S26, mitochondrial, transcript variant X2
probable 28S ribosomal protein S26, mitochondrial isoform X2
probable 28S ribosomal protein S26, mitochondrial, transcript variant X1
probable 28S ribosomal protein S26, mitochondrial isoform X1
mothers against decapentaplegic homolog 4, transcript variant X7
mothers against decapentaplegic homolog 4, transcript variant X8
mothers against decapentaplegic homolog 4, transcript variant X4
mothers against decapentaplegic homolog 4, transcript variant X6
mothers against decapentaplegic homolog 4, transcript variant X2
mothers against decapentaplegic homolog 4, transcript variant X3
mothers against decapentaplegic homolog 4, transcript variant X1
mothers against decapentaplegic homolog 4, transcript variant X5
mothers against decapentaplegic homolog 4 isoform X3
mothers against decapentaplegic homolog 4 isoform X6
mothers against decapentaplegic homolog 4 isoform X5
mothers against decapentaplegic homolog 4 isoform X4
mothers against decapentaplegic homolog 4 isoform X2
mothers against decapentaplegic homolog 4 isoform X1
transmembrane emp24 domain-containing protein eca
protein stunted-like, transcript variant X1
protein stunted-like, transcript variant X2
negative elongation factor D, transcript variant X1
negative elongation factor D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
putative lipoyltransferase 2, mitochondrial
ectopic P granules protein 5 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
ectopic P granules protein 5 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
ectopic P granules protein 5 homolog, transcript variant X1
ectopic P granules protein 5 homolog isoform X3
ectopic P granules protein 5 homolog isoform X2
ectopic P granules protein 5 homolog isoform X1
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
solute carrier family 49 member 4 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X2
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X3
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X4
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog, transcript variant X1
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog isoform X2
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog isoform X3
heterogeneous nuclear ribonucleoprotein A1, A2/B1 homolog isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
AP-2 complex subunit mu, transcript variant X1
AP-2 complex subunit mu, transcript variant X2
calmodulin-binding transcription activator 2, transcript variant X4
calmodulin-binding transcription activator 2, transcript variant X1
calmodulin-binding transcription activator 2, transcript variant X3
calmodulin-binding transcription activator 2, transcript variant X5
calmodulin-binding transcription activator 2, transcript variant X2
calmodulin-binding transcription activator 2 isoform X1
calmodulin-binding transcription activator 2 isoform X4
calmodulin-binding transcription activator 2 isoform X3
calmodulin-binding transcription activator 2 isoform X2
calmodulin-binding transcription activator 2, transcript variant X6
calmodulin-binding transcription activator 2 isoform X5
RING finger protein nhl-1, transcript variant X3
RING finger protein nhl-1, transcript variant X1
RING finger protein nhl-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
RING finger protein nhl-1, transcript variant X4
101 kDa malaria antigen-like, transcript variant X1
101 kDa malaria antigen-like, transcript variant X2
golgin subfamily A member 6-like protein 22 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
atypical protein kinase C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
atypical protein kinase C, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
atypical protein kinase C, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
atypical protein kinase C, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
cytochrome c oxidase subunit 4 isoform 1, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ubiquinone biosynthesis O-methyltransferase, mitochondrial, transcript variant X1
ubiquinone biosynthesis O-methyltransferase, mitochondrial, transcript variant X3
ubiquinone biosynthesis O-methyltransferase, mitochondrial, transcript variant X2
ubiquinone biosynthesis O-methyltransferase, mitochondrial
trans-1,2-dihydrobenzene-1,2-diol dehydrogenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
venom allergen 5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
venom allergen 5-like, transcript variant X2
venom allergen 5-like, transcript variant X1
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X1
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X3
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X2
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X5
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X6
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X4
calcium-binding mitochondrial carrier protein Aralar1, transcript variant X7
calcium-binding mitochondrial carrier protein Aralar1 isoform X5
calcium-binding mitochondrial carrier protein Aralar1 isoform X3
calcium-binding mitochondrial carrier protein Aralar1 isoform X2
calcium-binding mitochondrial carrier protein Aralar1 isoform X1
calcium-binding mitochondrial carrier protein Aralar1 isoform X4
calcium-binding mitochondrial carrier protein Aralar1 isoform X6
protein transport protein Sec24C, transcript variant X3
protein transport protein Sec24C, transcript variant X2
protein transport protein Sec24C, transcript variant X1
protein transport protein Sec24C, transcript variant X4
protein transport protein Sec24C isoform X1
protein transport protein Sec24C isoform X2
heparan-alpha-glucosaminide N-acetyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X1
putative mediator of RNA polymerase II transcription subunit 26, transcript variant X2
putative mediator of RNA polymerase II transcription subunit 26 isoform X1
putative mediator of RNA polymerase II transcription subunit 26 isoform X2
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X5
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X3
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X4
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X2
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X1
protein tyrosine phosphatase domain-containing protein 1-like, transcript variant X6
protein tyrosine phosphatase domain-containing protein 1-like isoform X1
protein tyrosine phosphatase domain-containing protein 1-like isoform X2
forkhead box protein P1-like, transcript variant X16
forkhead box protein P1-like, transcript variant X14
forkhead box protein P1-like, transcript variant X18
forkhead box protein P1-like, transcript variant X17
forkhead box protein P1-like, transcript variant X12
forkhead box protein P1-like, transcript variant X19
forkhead box protein P1-like, transcript variant X15
forkhead box protein P1-like, transcript variant X20
forkhead box protein P1-like, transcript variant X22
forkhead box protein P1-like, transcript variant X21
forkhead box protein P1-like, transcript variant X1
forkhead box protein P1-like, transcript variant X13
forkhead box protein P1-like, transcript variant X5
forkhead box protein P1-like, transcript variant X3
forkhead box protein P1-like, transcript variant X11
forkhead box protein P1-like, transcript variant X8
forkhead box protein P1-like, transcript variant X10
forkhead box protein P1-like, transcript variant X4
forkhead box protein P1-like, transcript variant X9
forkhead box protein P1-like, transcript variant X2
forkhead box protein P1-like, transcript variant X7
forkhead box protein P1-like, transcript variant X6
forkhead box protein P1-like isoform X17
forkhead box protein P1-like isoform X16
forkhead box protein P1-like isoform X14
forkhead box protein P1-like isoform X12
forkhead box protein P1-like isoform X15
forkhead box protein P1-like isoform X13
forkhead box protein P1-like isoform X11
forkhead box protein P1-like isoform X10
forkhead box protein P1-like isoform X18
forkhead box protein P1-like isoform X19
forkhead box protein P1-like, transcript variant X23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
histone deacetylase complex subunit SAP18
dual serine/threonine and tyrosine protein kinase-like, transcript variant X7
dual serine/threonine and tyrosine protein kinase-like, transcript variant X1
dual serine/threonine and tyrosine protein kinase-like, transcript variant X2
dual serine/threonine and tyrosine protein kinase-like isoform X4
dual serine/threonine and tyrosine protein kinase-like isoform X1
dual serine/threonine and tyrosine protein kinase-like isoform X2
dual serine/threonine and tyrosine protein kinase-like, transcript variant X6
dual serine/threonine and tyrosine protein kinase-like, transcript variant X4
dual serine/threonine and tyrosine protein kinase-like, transcript variant X5
dual serine/threonine and tyrosine protein kinase-like, transcript variant X3
dual serine/threonine and tyrosine protein kinase-like isoform X3
uncharacterized LOC122630453, transcript variant X2
uncharacterized LOC122630453, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122630453, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
peroxisome biogenesis factor 10-like, transcript variant X5
peroxisome biogenesis factor 10-like, transcript variant X1
peroxisome biogenesis factor 10-like, transcript variant X2
peroxisome biogenesis factor 10-like, transcript variant X3
peroxisome biogenesis factor 10-like, transcript variant X7
peroxisome biogenesis factor 10-like, transcript variant X6
peroxisome biogenesis factor 10-like, transcript variant X4
myotubularin-related protein 14, transcript variant X5
myotubularin-related protein 14 isoform X2
myotubularin-related protein 14, transcript variant X3
myotubularin-related protein 14, transcript variant X4
myotubularin-related protein 14, transcript variant X2
myotubularin-related protein 14, transcript variant X1
myotubularin-related protein 14 isoform X1
ADP-ribose pyrophosphatase, mitochondrial, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
ADP-ribose pyrophosphatase, mitochondrial, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
ADP-ribose pyrophosphatase, mitochondrial isoform X1
ADP-ribose pyrophosphatase, mitochondrial isoform X2
uncharacterized LOC122630355, transcript variant X11
uncharacterized protein LOC122630355 isoform X4
uncharacterized LOC122630355, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
uncharacterized protein LOC122630355 isoform X5
uncharacterized LOC122630355, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X9
uncharacterized LOC122630355, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X1
uncharacterized LOC122630355, transcript variant X6
uncharacterized LOC122630355, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC122630355, transcript variant X14
uncharacterized protein LOC122630355 isoform X7
uncharacterized protein LOC122630355 isoform X1
uncharacterized protein LOC122630355 isoform X3
uncharacterized protein LOC122630355 isoform X2
uncharacterized LOC122630355, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122630355 isoform X6
uncharacterized LOC122630370, transcript variant X3
uncharacterized LOC122630370, transcript variant X2
uncharacterized LOC122630370, transcript variant X1
ankyrin repeat domain-containing protein 12
transmembrane protein 70 homolog, mitochondrial
nuclear pore complex protein Nup98-Nup96, transcript variant X2
nuclear pore complex protein Nup98-Nup96, transcript variant X1
nuclear pore complex protein Nup98-Nup96 isoform X2
nuclear pore complex protein Nup98-Nup96 isoform X1
C2 domain-containing protein 5, transcript variant X1
C2 domain-containing protein 5 isoform X1
C2 domain-containing protein 5, transcript variant X2
C2 domain-containing protein 5 isoform X2
SUMO-activating enzyme subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
SUMO-activating enzyme subunit 2, transcript variant X1
SUMO-activating enzyme subunit 2 isoform X1
SUMO-activating enzyme subunit 2 isoform X2
YTH domain-containing protein 1, transcript variant X2
YTH domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
uncharacterized LOC122630834, transcript variant X4
uncharacterized LOC122630834, transcript variant X2
uncharacterized LOC122630834, transcript variant X1
uncharacterized LOC122630834, transcript variant X3
uncharacterized protein LOC122630834 isoform X1
uncharacterized protein LOC122630834 isoform X2
uncharacterized protein LOC122630834 isoform X4
uncharacterized protein LOC122630834 isoform X3
vascular endothelial growth factor A-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
nucleoprotein TPR-like, transcript variant X2
nucleoprotein TPR-like, transcript variant X1
pentatricopeptide repeat-containing protein 1, mitochondrial
protein virilizer, transcript variant X2
protein virilizer, transcript variant X1
protein virilizer, transcript variant X3
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase, transcript variant X1
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase, transcript variant X2
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase isoform X1
type 1 phosphatidylinositol 4,5-bisphosphate 4-phosphatase isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X5
serine/threonine-protein phosphatase 2B catalytic subunit 2-like, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit 2-like isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
glutathione S-transferase-like, transcript variant X2
glutathione S-transferase-like, transcript variant X1
glutathione S-transferase-like, transcript variant X3
glutathione S-transferase-like isoform X1
glutathione S-transferase-like isoform X2
glutamyl aminopeptidase-like, transcript variant X1
glutamyl aminopeptidase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamyl aminopeptidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
puromycin-sensitive aminopeptidase-like protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
xanthine dehydrogenase/oxidase-like, transcript variant X1
xanthine dehydrogenase/oxidase-like, transcript variant X2
xanthine dehydrogenase/oxidase-like isoform X1
xanthine dehydrogenase/oxidase-like isoform X2
uncharacterized LOC122630514, transcript variant X3
uncharacterized LOC122630514, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122630514, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sorting nexin-25-like, transcript variant X2
sorting nexin-25-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
inositol hexakisphosphate kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
inositol hexakisphosphate kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
inositol hexakisphosphate kinase 1 isoform X1
inositol polyphosphate multikinase isoform X2
chromodomain-helicase-DNA-binding protein 7, transcript variant X4
chromodomain-helicase-DNA-binding protein 7, transcript variant X2
chromodomain-helicase-DNA-binding protein 7, transcript variant X1
chromodomain-helicase-DNA-binding protein 7, transcript variant X3
chromodomain-helicase-DNA-binding protein 7 isoform X4
chromodomain-helicase-DNA-binding protein 7 isoform X2
chromodomain-helicase-DNA-binding protein 7 isoform X1
chromodomain-helicase-DNA-binding protein 7 isoform X3
huntingtin-interacting protein 1, transcript variant X2
huntingtin-interacting protein 1, transcript variant X3
huntingtin-interacting protein 1, transcript variant X1
huntingtin-interacting protein 1 isoform X2
huntingtin-interacting protein 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
nuclear pore complex protein Nup154, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nuclear pore complex protein Nup154, transcript variant X5
nuclear pore complex protein Nup154, transcript variant X3
nuclear pore complex protein Nup154, transcript variant X4
nuclear pore complex protein Nup154, transcript variant X2
nuclear pore complex protein Nup154, transcript variant X1
eukaryotic translation initiation factor 2-alpha kinase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
eukaryotic translation initiation factor 2-alpha kinase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
eukaryotic translation initiation factor 2-alpha kinase, transcript variant X2
eukaryotic translation initiation factor 2-alpha kinase isoform X1
eukaryotic translation initiation factor 2-alpha kinase isoform X2
eukaryotic translation initiation factor 2-alpha kinase isoform X3
small G protein signaling modulator 3 homolog, transcript variant X1
small G protein signaling modulator 3 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
small G protein signaling modulator 3 homolog isoform X1
small G protein signaling modulator 3 homolog isoform X2
solute carrier family 25 member 36, transcript variant X3
solute carrier family 25 member 36, transcript variant X2
solute carrier family 25 member 36, transcript variant X1
A-kinase anchor protein 9-like, transcript variant X1
A-kinase anchor protein 9-like, transcript variant X8
A-kinase anchor protein 9-like, transcript variant X5
A-kinase anchor protein 9-like, transcript variant X3
A-kinase anchor protein 9-like, transcript variant X4
A-kinase anchor protein 9-like, transcript variant X6
A-kinase anchor protein 9-like, transcript variant X7
A-kinase anchor protein 9-like, transcript variant X2
golgin subfamily A member 4-like isoform X1
A-kinase anchor protein 9-like isoform X7
A-kinase anchor protein 9-like isoform X4
A-kinase anchor protein 9-like isoform X2
A-kinase anchor protein 9-like isoform X3
golgin subfamily A member 4-like isoform X5
A-kinase anchor protein 9-like isoform X6
2-phosphoxylose phosphatase 1, transcript variant X2
2-phosphoxylose phosphatase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
2-phosphoxylose phosphatase 1 isoform X1
2-phosphoxylose phosphatase 1 isoform X2
patched domain-containing protein 3, transcript variant X2
patched domain-containing protein 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
patched domain-containing protein 3, transcript variant X1
patched domain-containing protein 3 isoform X1
uncharacterized protein LOC122630661 isoform X2
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122630674, transcript variant X4
uncharacterized LOC122630674, transcript variant X3
uncharacterized LOC122630674, transcript variant X2
uncharacterized LOC122630674, transcript variant X1
period circadian protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
period circadian protein, transcript variant X2
ecdysone receptor-like, transcript variant X2
ecdysone receptor-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ecdysone receptor-like, transcript variant X1
neprilysin-1-like, transcript variant X2
neprilysin-1-like, transcript variant X1
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122630660, transcript variant X2
uncharacterized LOC122630660, transcript variant X3
uncharacterized LOC122630660, transcript variant X1
uncharacterized LOC122630660, transcript variant X6
uncharacterized LOC122630660, transcript variant X5
uncharacterized LOC122630660, transcript variant X4
peptidyl-prolyl cis-trans isomerase sig-7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
tRNA (uracil-5-)-methyltransferase homolog A-like, transcript variant X2
tRNA (uracil-5-)-methyltransferase homolog A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
tRNA (uracil-5-)-methyltransferase homolog A-like isoform X1
tRNA (uracil-5-)-methyltransferase homolog A-like isoform X2
lon protease homolog, mitochondrial, transcript variant X1
lon protease homolog, mitochondrial, transcript variant X2
lon protease homolog, mitochondrial isoform X1
lon protease homolog, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
WAS/WASL-interacting protein family member 1-like, transcript variant X3
WAS/WASL-interacting protein family member 1-like, transcript variant X1
WAS/WASL-interacting protein family member 1-like, transcript variant X2
WAS/WASL-interacting protein family member 1-like isoform X2
WAS/WASL-interacting protein family member 1-like isoform X1
ATP-binding cassette sub-family F member 3
uncharacterized LOC122630766, transcript variant X3
uncharacterized LOC122630766, transcript variant X2
uncharacterized LOC122630766, transcript variant X1
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X6
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X7
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X1
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X2
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X4
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X2
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X7
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X1
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X6
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X3
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X4
chromodomain-helicase-DNA-binding protein Mi-2 homolog, transcript variant X5
chromodomain-helicase-DNA-binding protein Mi-2 homolog isoform X5
dnaJ homolog subfamily B member 6-like, transcript variant X1
dnaJ homolog subfamily B member 6-like, transcript variant X3
dnaJ homolog subfamily B member 6-like, transcript variant X2
dnaJ homolog subfamily B member 6-like isoform X1
dnaJ homolog subfamily B member 6-like isoform X2
putative acyl-CoA-binding protein, transcript variant X1
putative acyl-CoA-binding protein, transcript variant X2
putative acyl-CoA-binding protein isoform X1
putative acyl-CoA-binding protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
von Willebrand factor A domain-containing protein 8, transcript variant X1
von Willebrand factor A domain-containing protein 8 isoform X1
von Willebrand factor A domain-containing protein 8, transcript variant X3
von Willebrand factor A domain-containing protein 8 isoform X2
uncharacterized LOC122630731, transcript variant X1
uncharacterized LOC122630731, transcript variant X2
uncharacterized protein LOC122630731 isoform X1
uncharacterized protein LOC122630731 isoform X2
uncharacterized LOC122630732, transcript variant X2
uncharacterized LOC122630732, transcript variant X1
uncharacterized LOC122630735, transcript variant X2
uncharacterized LOC122630735, transcript variant X1
MATH and LRR domain-containing protein PFE0570w-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
semaphorin-2A-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
semaphorin-2A-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
semaphorin-2A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
semaphorin-2A-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
semaphorin-2A-like, transcript variant X2
semaphorin-2A-like, transcript variant X5
semaphorin-2A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC122630346, transcript variant X1
uncharacterized LOC122630346, transcript variant X2
uncharacterized protein LOC122630346 isoform X1
uncharacterized protein LOC122630346 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
bromodomain-containing protein 4-like isoform X2
BTB/POZ domain-containing protein 1-like, transcript variant X2
BTB/POZ domain-containing protein 1-like, transcript variant X1
BTB/POZ domain-containing protein 1-like isoform X2
BTB/POZ domain-containing protein 1-like isoform X1
uncharacterized LOC122630497, transcript variant X1
uncharacterized LOC122630497, transcript variant X3
uncharacterized LOC122630497, transcript variant X2
uncharacterized LOC122630501, transcript variant X2
uncharacterized LOC122630501, transcript variant X1
probable ribosome biogenesis protein RLP24
neither inactivation nor afterpotential protein G
zinc finger protein chinmo, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger protein chinmo, transcript variant X1
zinc finger protein chinmo, transcript variant X5
zinc finger protein chinmo, transcript variant X6
zinc finger protein chinmo, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein chinmo, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
zinc finger protein chinmo, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial, transcript variant X2
cytochrome b-c1 complex subunit Rieske, mitochondrial, transcript variant X1
cytochrome b-c1 complex subunit Rieske, mitochondrial isoform X2
cytochrome b-c1 complex subunit Rieske, mitochondrial isoform X1
coiled-coil domain-containing protein 43
dual specificity tyrosine-phosphorylation-regulated kinase mbk-2-like, transcript variant X1
dual specificity tyrosine-phosphorylation-regulated kinase mbk-2-like, transcript variant X2
dual specificity tyrosine-phosphorylation-regulated kinase mbk-2-like isoform X2
probable serine/threonine-protein kinase dyrk2 isoform X1
uncharacterized LOC122630616, transcript variant X3
uncharacterized LOC122630616, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC122630616, transcript variant X2
DNA repair endonuclease XPF, transcript variant X1
DNA repair endonuclease XPF, transcript variant X2
uncharacterized LOC122630610, transcript variant X1
uncharacterized LOC122630610, transcript variant X2
uncharacterized LOC122630610, transcript variant X3
uncharacterized protein LOC122630610 isoform X2
uncharacterized protein LOC122630610 isoform X1
uncharacterized LOC122630716, transcript variant X2
uncharacterized LOC122630716, transcript variant X1
uncharacterized LOC122630716, transcript variant X3
uncharacterized protein LOC122630716 isoform X2
uncharacterized protein LOC122630716 isoform X1
uncharacterized protein LOC122630716 isoform X3
metalloproteinase inhibitor 1, transcript variant X4
metalloproteinase inhibitor 1, transcript variant X3
metalloproteinase inhibitor 1, transcript variant X1
metalloproteinase inhibitor 1 isoform X1
metalloproteinase inhibitor 1, transcript variant X2
metalloproteinase inhibitor 1, transcript variant X5
metalloproteinase inhibitor 1 isoform X2
uncharacterized LOC122630403, transcript variant X2
uncharacterized LOC122630403, transcript variant X1
uncharacterized protein LOC122630403 isoform X1
uncharacterized protein LOC122630403 isoform X2
uncharacterized LOC122630403, transcript variant X3
uncharacterized protein LOC122630403 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
troponin C, isoallergen Bla g 6.0101-like, transcript variant X2
troponin C, isoallergen Bla g 6.0101-like, transcript variant X1
troponin C, isoallergen Bla g 6.0101-like isoform X1
troponin C, isoallergen Bla g 6.0101-like isoform X2